23h
MedPage Today on MSNSotatercept Helps the Sickest Patients With Pulmonary Arterial HypertensionAdding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk patients ...
16h
News-Medical.Net on MSNWINREVAIR™ (sotatercept-csrk) reduced the risk of a composite of all-cause death, lung transplantation and hospitalization for pulmonary arterial hypertension (PAH) …Merck, known as MSD outside of the United States and Canada, today announced the first presentation of results from the Phase ...
From sleep deprivation to diabetes prevention, the event included sessions by renowned experts. It underlined the importance ...
6h
Verywell Health on MSN5 Ways 5-HTP May Boost Your HealthHTP is a popular supplement that can increase levels of the hormone serotonin in the brain. But very little evidence supports ...
Patients without diabetes using GLP-1RAs are less likely to develop glaucoma compared with those who use other weight loss therapies.
I took the diet drug Redux in the late 1990s. It was pulled off the market due to correlated heart issues. I saw a cardiologist and learned that ...
Main pulmonary artery diameter is a prognostic indicator in patients with pulmonary arterial hypertension without congenital heart disease.
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) has become the most prevalent type of heart failure, but ...
Every hour, one person in the United States dies from oral and oropharyngeal cancer. Yet, when detected early, the survival rate can be as high as 90 percent. This April, the American Association of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results